Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Lemez, P; Attarbaschi, A; Béné, MC; Bertrand, Y; Castoldi, G; Forestier, E; Garand, R; Haas, OA; Kagialis-Girard, S; Ludwig, WD; Matutes, E; Mejstríková, E; Pages, MP; Pickl, W; Porwit, A; Orfao, A; Schabath, R; Starı, J; Strobl, H; Talmant, P; van't Veer, MB; Zemanová, Z; European Group for the Immunological Characterization of Leukemias (EGIL).
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.
Eur J Haematol. 2010; 85(4):300-308
Doi: 10.1111/j.1600-0609.2010.01493.x
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Strobl Herbert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Objectives: Patients with near-tetraploid (karyotype: 81 - 103 chromosomes) acute lymphoblastic leukemia (NT-ALL) constitute about 1% of childhood ALL and data reported on them are limited and controversial. The aim of the study was to enlarge the knowledge on these rarely occurring ALL. Methods: The members of the European Group for Immunophenotyping of Leukemias (EGIL) searched retrospectively their databases for NT-ALL patients. Results: We collected data of 36 European children from seven European countries with NT-ALL diagnosed since 1992. All patients reached complete remission (CR) after induction chemotherapy. Their blasts were negative for peroxidase and BCR-ABL1. Ten children were diagnosed as T-cell ALL (T-ALL) EGIL categories (T-I n = 2, T-II n = 2, T-III n = 3, T-IV n = 3) and four displayed various structural chromosomal abnormalities. Eight of 10 T-ALL remained in 1st CR; one died in CR from sepsis and one is alive in 2nd CR. Median survival was 88 (7-213) months. B-cell precursor (BCP) ALL was diagnosed in 26 children. Thirteen were positive for ETV6-RUNX1 and are alive in 1st CR for 32-147 months. Ten children were ETV6-RUNX1 negative and remained in 1st CR for 16-163 months. One girl with hypodiploid and NT metaphases and ETV6-RUNX1-negative BCP-ALL and one of two boys with NT-BCP-ALL not examined for ETV6-RUNX1 died of infection after stem cell transplantation in 2nd/3rd CR. Secondary myelodysplastic syndrome developed in two patients with NT-BCP-ALL. Conclusions: Our data demonstrate immunophenotypic, cytogenetic, and molecular heterogeneity of NT-ALL and favorable prognosis of most NT-ALL across different immunophenotypic and/or genetic ALL subtypes.
- Find related publications in this database (using NLM MeSH Indexing)
-
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
-
Child -
-
Chromosome Aberrations -
-
Core Binding Factor Alpha 2 Subunit -
-
Core Binding Factor Alpha 2 Subunit -
-
Female -
-
Fusion Proteins, bcr-abl - genetics
-
Humans -
-
Immunophenotyping -
-
Karyotyping -
-
Male -
-
Oncogene Proteins, Fusion - genetics
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
-
Prognosis -
-
Remission Induction -
-
Retrospective Studies -
-
Survival Analysis -
-
Treatment Outcome -
- Find related publications in this database (Keywords)
-
Tetraploid acute lymphoblastic leukemia
-
polyploidy
-
childhood
-
classification
-
immunophenotyping
-
molecular genetics
-
prognosis